DNAJC10 and central nervous system cancer: Further, the significance of DNAJC10 expression varies among different cancers; for example, high DNAJC10 expression is associated with poor prognosis in patients with glioma,31 while DNAJC10 mRNA downregulation predicts weak OS and relapse‐free survival in patients with breast cancer.32